Highly active antiretroviral therapy and hospital readmission: comparison of a matched cohort
<p>Abstract</p> <p>Background</p> <p>Despite the known efficacy of highly active antiretroviral therapy (HAART), a large proportion of potentially-eligible HIV-infected patients do not access, and may stand to benefit from this treatment. In order to quantify these bene...
Main Authors: | Li Xin, Sun Huiying, Nosyk Bohdan, Palepu Anita, Anis Aslam H |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-10-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/6/146 |
Similar Items
-
Readmission rates of patients discharged against medical advice: a matched cohort study.
by: Mark Choi, et al.
Published: (2011-01-01) -
Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
by: Marianne Harris, et al.
Published: (2012-01-01) -
Length of hospital stay after hip fracture and readmission rates of persons with and without Alzheimer’s disease: a matched cohort study
by: Blair Rajamaki, et al.
Published: (2020-06-01) -
Risk factors for hospital readmission of patients with heart failure: A cohort study
by: Adel Sadeq, et al.
Published: (2020-01-01) -
Empirical studies in opioid dependence
by: Nosyk, Bohdan
Published: (2010)